News from us and our partners

Tags

Topics

0 results

News
28 October, 2024
AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)
News
24 October, 2024
deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI
News
23 October, 2024
Bioptimus and Proscia collaborate to accelerate AI innovation in scientific research and drug development for improved patient care
News
22 October, 2024
Enhanced data security and quality via ISO 27001:2022 and SOC 2 certifications enables Moon Surgical to deliver actionable insights to healthcare providers
News
22 October, 2024
Gradient Denervation Technologies appoints Stanton Rowe to Board of Directors and receives FDA approval to expand early feasibility study
News
21 October, 2024
AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer
News
17 October, 2024
Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
News
17 October, 2024
Biotalys appoints Kamal El Mernissi as Chief Business Development Officer
News
16 October, 2024
Biotalys announces closing of private placement
News
15 October, 2024
Sofinnova welcomes Agnès Pauquet as Head of Human Resources
News
15 October, 2024
Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signaling a key step towards commercialisation
News
14 October, 2024
Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
News
9 October, 2024
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
News
30 September, 2024
Pi-Cardia receives FDA market clearance for ShortCut™
News
25 September, 2024
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic
News
23 September, 2024
Sensorion reports new positive clinical results presented at the World Congress of Audiology

AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)

deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI

Bioptimus and Proscia collaborate to accelerate AI innovation in scientific research and drug development for improved patient care

Enhanced data security and quality via ISO 27001:2022 and SOC 2 certifications enables Moon Surgical to deliver actionable insights to healthcare providers

Gradient Denervation Technologies appoints Stanton Rowe to Board of Directors and receives FDA approval to expand early feasibility study

AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer

Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints

Biotalys appoints Kamal El Mernissi as Chief Business Development Officer

Biotalys announces closing of private placement

Sofinnova welcomes Agnès Pauquet as Head of Human Resources

Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signaling a key step towards commercialisation

Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases

Pi-Cardia receives FDA market clearance for ShortCut™

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic

Sensorion reports new positive clinical results presented at the World Congress of Audiology